3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
3
Lung Neoplasms
2
Esophageal Neoplasms
2
Anatomic Stage II Breast Cancer AJCC v8
2
Uterine Neoplasms
1
Uterine Cervical Neoplasms
1
Urinary Bladder Neoplasms
1
Thyroid Neoplasms
1
Stomach Neoplasms
1
Salivary Gland Neoplasms
1
Rectal Neoplasms
1
Prostatic Neoplasms
1
Pancreatic Neoplasms
1
Ovarian Neoplasms
1
Multiple Myeloma
1
Melanoma
1
Malignant Solid Neoplasm
1
Lymphoma
1
Hematologic Neoplasms
1
Glioma
1
Endometrial Neoplasms
1
Colorectal Neoplasms
1
Colonic Neoplasms
1
Carcinoma, Renal Cell
1
Carcinoma, Non-Small-Cell Lung
1
Carcinoma, Hepatocellular
1
Anatomic Stage IV Breast Cancer AJCC v8
1
Anatomic Stage I Breast Cancer AJCC v8
1
Advanced Breast Carcinoma
1
Adenocarcinoma Of Esophagus
1
Interventions
Tamoxifen
7
Specimen Handling
7
exemestane
3
Letrozole
3
Anastrozole
3
Radiotherapy, Intensity-Modulated
2
Radiotherapy, Conformal
2
Radiation Dose Hypofractionation
2
Biopsy
2
ruxolitinib
1
poly ICLC
1
fezolinetant
1
elacestrant
1
Testosterone
1
Surveys and Questionnaires
1
Surgical Procedures, Operative
1
Selective Estrogen Receptor Modulators
1
Radiotherapy
1
Radiation
1
Protons
1
Proton Therapy
1
Omacor
1
Neoadjuvant Therapy
1
Multicenter Studies as Topic
1
Metformin
1
Medicare
1
Mastectomy, Segmental
1
Mastectomy
1
Magnetic Resonance Spectroscopy
1
High-Energy Shock Waves
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Carcinoma, Intraductal, Noninfiltrating
×
PF-05280014
×
90 days
×
Clear all
No trials found.